4 min read · 17 February 2011
Diartis Pharmaceuticals Inc. has raised an undisclosed amount of financing from Index Ventures, biotechnology company Amunix Inc. and other, undisclosed investors. Mountain View, Calif.-based Diartis is a biotechnology company developing therapeutics for the treatment of metabolic diseases.
3 min read · 16 February 2011
Canadian venture capital investments in 2010 increased in value for the first time in three years, Reuters reported. According to data compiled by the Canadian Venture Capital and Private Equity Association and Thomson Reuters, 1.1 billion Canadian dollars ($1.11 billion) of venture capital was invested in 354 companies, Reuters wrote. The figure is still down from the 1.4 billion Canadian dollars invested in 2008.
2 min read · 16 February 2011
Solvate has raised $4 million in Series B financing from RRE Ventures, DFJ Gotham and the company’s chief executive, Michael Paolucci. Solvate, based in New York, develops a platform designed to help employers and independent professionals work productively together in the cloud. The company closed a $2.3 million round in late 2009.
3 min read · 16 February 2011
Seattle-based Doxo, which develops secure “digital file cabinet” technology for receiving and organizing bills and other important documents, has closed a $10 million Series B round. Sigma Partners led the round, which included participation from Series A investors Mohr Davidow Ventures and Bezos Expeditions.
4 min read · 16 February 2011
San Diego-based ecoATM, which develops kiosks that buy-back and recycle consumer electronics, has raised $14.4 million in Series A equity financing and debt financing. Coinstar Inc. and Claremont Creek Ventures led the round. Silicon Valley Bank is providing venture debt to the company. The money will be used for commercialization and product launch. Claremont Creek managing director Randy Hawks joins the company’s board as a result of the round, as does a representative from Coinstar subsidiary Redbox.
4 min read · 16 February 2011
Activaero GmbH, a German developer of controlled breathing inhalation devices, has raised 5 million euro ($6.8 million) in venture capital financing. Amsterdam-based LSP Life Sciences Partners led the round with a 3.5 million euro investment. The firm was joined by existing shareholders including BioMedPartners, VI Partners, Abalis Finance, Vesalius Biocapital I SICAR, MedVenture Partners.
2 min read · 16 February 2011
Cuculus GmbH, a German developer of metering and home control products, has raised an undisclosed amount of venture financing from T Venture. The firm joins existing shareholders Yellow&Blue Clean Energy Investments, KfW, High-Tech Gruunderfonds and Siegmund Beteiligungsgesellschaft, who invested 2.6 million euro in the company in February 2010.
3 min read · 16 February 2011
Mountain View, Calif.-based biotech company Versartis Inc., which is developing therapeutics to treat endocrine disorders, has raised $21 million in funding. New Leaf Venture Partners led the Series B round, which included participation from Advent Venture Partners' Advent Life Sciences fund and existing shareholders Index Ventures and Amunix. The money will help Versartis conduct clinical trials of its product for growth hormone deficiency.
4 min read · 16 February 2011
5 min read · 15 February 2011
